000 | 01059 a2200313 4500 | ||
---|---|---|---|
005 | 20250512015218.0 | ||
264 | 0 | _c19890811 | |
008 | 198908s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPendleton, R G | |
245 | 0 | 0 |
_aStudies defining minimal receptor domains for angiotensin II. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cJul 1989 |
||
300 |
_a31-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdrenal Glands _xmetabolism |
650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aCell Membrane _xmetabolism |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aReceptors, Angiotensin _xmetabolism |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aGessner, G | |
700 | 1 | _aHorner, E | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 250 _gno. 1 _gp. 31-6 |
|
999 |
_c2752382 _d2752382 |